Calvopiña, K., Umland, K., Rydzik, A., Hinchliffe, P., Brem, J., Spencer, J., . . . Avison, M. (2016). Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. American Society for Microbiology.
Chicago-referens (17:e uppl.)Calvopiña, K., K. Umland, A. Rydzik, P. Hinchliffe, J. Brem, J. Spencer, C. Schofield, och M. Avison. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.
MLA-referens (9:e uppl.)Calvopiña, K., et al. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.